323 related articles for article (PubMed ID: 38305570)
1. Astroglial activation: Current concepts and future directions.
Edison P
Alzheimers Dement; 2024 Apr; 20(4):3034-3053. PubMed ID: 38305570
[TBL] [Abstract][Full Text] [Related]
2. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases.
Li L; Acioglu C; Heary RF; Elkabes S
Brain Behav Immun; 2021 Jan; 91():740-755. PubMed ID: 33039660
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes.
Kwon HS; Koh SH
Transl Neurodegener; 2020 Nov; 9(1):42. PubMed ID: 33239064
[TBL] [Abstract][Full Text] [Related]
4. Astroglial Connexins in Neurodegenerative Diseases.
Huang X; Su Y; Wang N; Li H; Li Z; Yin G; Chen H; Niu J; Yi C
Front Mol Neurosci; 2021; 14():657514. PubMed ID: 34122008
[TBL] [Abstract][Full Text] [Related]
5. Pathological Neuroinflammatory Conversion of Reactive Astrocytes Is Induced by Microglia and Involves Chromatin Remodeling.
Villarreal A; Vidos C; Monteverde Busso M; Cieri MB; Ramos AJ
Front Pharmacol; 2021; 12():689346. PubMed ID: 34234677
[TBL] [Abstract][Full Text] [Related]
6. Diversity of astroglial responses across human neurodegenerative disorders and brain aging.
Ferrer I
Brain Pathol; 2017 Sep; 27(5):645-674. PubMed ID: 28804999
[TBL] [Abstract][Full Text] [Related]
7. Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.
Darreh-Shori T; Vijayaraghavan S; Aeinehband S; Piehl F; Lindblom RP; Nilsson B; Ekdahl KN; Långström B; Almkvist O; Nordberg A
Neurobiol Aging; 2013 Nov; 34(11):2465-81. PubMed ID: 23759148
[TBL] [Abstract][Full Text] [Related]
8. APOE mediated neuroinflammation and neurodegeneration in Alzheimer's disease.
Parhizkar S; Holtzman DM
Semin Immunol; 2022 Jan; 59():101594. PubMed ID: 35232622
[TBL] [Abstract][Full Text] [Related]
9. Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes.
Santiago-Balmaseda A; Aguirre-Orozco A; Valenzuela-Arzeta IE; Villegas-Rojas MM; Pérez-Segura I; Jiménez-Barrios N; Hurtado-Robles E; Rodríguez-Hernández LD; Rivera-German ER; Guerra-Crespo M; Martinez-Fong D; Ledesma-Alonso C; Diaz-Cintra S; Soto-Rojas LO
Cells; 2024 May; 13(11):. PubMed ID: 38891053
[TBL] [Abstract][Full Text] [Related]
10. All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer's disease.
St-Pierre MK; VanderZwaag J; Loewen S; Tremblay MÈ
Front Cell Neurosci; 2022; 16():932572. PubMed ID: 36035256
[TBL] [Abstract][Full Text] [Related]
11. Contribution of astrocytes to neuropathology of neurodegenerative diseases.
Acioglu C; Li L; Elkabes S
Brain Res; 2021 May; 1758():147291. PubMed ID: 33516810
[TBL] [Abstract][Full Text] [Related]
12. Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma.
Yang X; Zeng Q; Barış M; Tezel G
J Neuroinflammation; 2020 Aug; 17(1):252. PubMed ID: 32859212
[TBL] [Abstract][Full Text] [Related]
13. Polar lipids modify Alzheimer's Disease pathology by reducing astrocyte pro-inflammatory signaling through platelet-activating factor receptor (PTAFR) modulation.
Hans S; Stanton JE; Sauer AK; Shiels K; Saha SK; Lordan R; Tsoupras A; Zabetakis I; Grabrucker AM
Lipids Health Dis; 2024 Apr; 23(1):113. PubMed ID: 38643113
[TBL] [Abstract][Full Text] [Related]
14. Prolyl oligopeptidase colocalizes with α-synuclein, β-amyloid, tau protein and astroglia in the post-mortem brain samples with Parkinson's and Alzheimer's diseases.
Hannula MJ; Myöhänen TT; Tenorio-Laranga J; Männistö PT; Garcia-Horsman JA
Neuroscience; 2013 Jul; 242():140-50. PubMed ID: 23562579
[TBL] [Abstract][Full Text] [Related]
15. [Abeta, tau and alpha-synuclein and glial cells].
Akiyama H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Feb; 26(1):23-31. PubMed ID: 16637593
[TBL] [Abstract][Full Text] [Related]
16. Astrocytes: a central element in neurological diseases.
Pekny M; Pekna M; Messing A; Steinhäuser C; Lee JM; Parpura V; Hol EM; Sofroniew MV; Verkhratsky A
Acta Neuropathol; 2016 Mar; 131(3):323-45. PubMed ID: 26671410
[TBL] [Abstract][Full Text] [Related]
17. Astroglial atrophy in Alzheimer's disease.
Verkhratsky A; Rodrigues JJ; Pivoriunas A; Zorec R; Semyanov A
Pflugers Arch; 2019 Oct; 471(10):1247-1261. PubMed ID: 31520182
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk signals in the CNS: role of neurotrophic and hormonal factors, adhesion molecules and intercellular signaling agents in luteinizing hormone-releasing hormone (LHRH)-astroglial interactive network.
Marchetti B
Front Biosci; 1997 Mar; 2():d88-125. PubMed ID: 9159216
[TBL] [Abstract][Full Text] [Related]
19. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
Makarava N; Chang JC; Molesworth K; Baskakov IV
Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
[TBL] [Abstract][Full Text] [Related]
20. Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease.
Yue Q; Hoi MPM
Neural Regen Res; 2023 Sep; 18(9):1890-1902. PubMed ID: 36926705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
